SAIL Form 144: 28,267 shares from RSU vesting slated for sale
Rhea-AI Filing Summary
SailPoint, Inc. insider filed a Form 144 to notify a proposed sale of 28,267 shares of common stock, with an aggregate market value of $637,525.44, intended to be sold on or about 10/07/2025 on Nasdaq. The shares were acquired on 10/05/2025 through RSU vesting and were recorded as 217,370 shares acquired on that date as compensation. The filing reports 556,635,292 shares outstanding. No sales by the reporting person in the prior three months were reported. The filer affirms there is no undisclosed material adverse information.
Positive
- Insider sale size is small relative to total outstanding shares (28,267 vs 556,635,292)
- Securities originated from RSU vesting, indicating compensation-related liquidity rather than debt-driven sale
Negative
- Insider plans to sell immediately (approximate sale date 10/07/2025), which could add short-term supply
- No 10b5-1 plan date disclosed in the filing, leaving execution intent less formalized
Insights
TL;DR: Insider sale follows recent RSU vesting; size is modest versus total float.
The filing shows 28,267 shares proposed for sale, which is a small fraction of the issuer's reported 556,635,292 outstanding shares (under 0.01%). The shares originated from an RSU vesting event reported on 10/05/2025, paid as compensation, indicating the transaction is not a purchase-based liquidation.
Key dependencies include the actual execution date around 10/07/2025 and market liquidity on Nasdaq. Watch short-term price impact the day of sale and whether additional scheduled vesting or plan-based sales are disclosed within standard reporting windows.
TL;DR: Aggregate value is material to the filer but immaterial to market cap.
An aggregate market value of $637,525.44 implies the sale is meaningful for the individual holder’s cashing event but represents a negligible portion of the company’s outstanding share base. The origin as compensation (RSUs) suggests routine insider liquidity rather than a company-wide change.
Risks include potential short-term volume spikes and disclosure timing; investors may note whether the filer uses a 10b5-1 plan (not indicated) or reports further sales in subsequent Form 4/144 filings.